Projects
The pharmaceutical projects listed in this phase are those that receive periodic global announcements.
Piramal Pharma Invests $80 Million to Expand Sterile Injectable Facility in Kentucky
Piramal Pharma Solutions PPS is investing $80M to expand its Lexington, Kentucky facility This site specializes in sterile injectable drug products, including compounding, liquid filling, and lyophilization The expansion will support PPSs ADCelerate
AstraZeneca Invests $3.5 Billion to Expand R&D and Manufacturing in the U.S
AstraZeneca has unveiled plans for a $35 billion capital investment in the United States to enhance its research and manufacturing capabilities This initiative includes $2 billion allocated to new projects, which are set to generate over a thousand highskilled jobs, bolstering
Grünenthal Invests €80 Million to Enhance Latin American Production
Grnenthal, a prominent pharmaceutical company specializing in pain management and research, has announced a significant investment in its Latin American production facilities, exceeding 80 million
Kyowa Kirin Plans $530 Million Investment for New Biologics Manufacturing Plant in North Carolina
Kyowa Kirin, Inc, a global specialty pharmaceutical company headquartered in Japan, has announced plans to invest up to $530 million in building a new manufacturing facility in Sanford, North Carolina
Merck Invests €62 Million in New Quality Control Center in Germany
Merck, a leading science and technology company, is investing 62 million in a new quality control facility for its Life Science division at its Darmstadt headquarters
AstraZeneca's $1.5B Investment in Singapore for Antibody Drug Conjugates
AstraZeneca has announced plans to invest $15 billion in a new manufacturing facility in Singapore dedicated to antibodydrug conjugates
AbbVie Invests €150 Million in New Research and Development Facility in Germany
AbbVie has initiated the construction of its new central research facility, LUnA, at its main campus in Ludwigshafen, RhinelandPalatinate, Germany
€80 Million Investment by GEA to Enhance Pharmaceutical Standards at Elsdorf Factory
GEA has announced a substantial investment of 80 million to enhance pharmaceutical production standards at its Elsdorf factory, aiming to modernize facilities and improve operational efficiency
Abzena Invests $5 Million to Expand Bioconjugation and ADC Capabilities
Abzena, a leading CDMO for complex biologics and bioconjugates, announced a significant expansion of its Bristol, PA site for bioconjugate development and cGMP manufacturing
Sandoz Breaks Ground on New Antibiotic Production Facility in Austria with EUR 50 Million Investment
Sandoz, a global leader in generic and biosimilar medicines, opens new production facility in Kundl, Austria Facility aims to provide affordable lifesaving drugs solely manufactured in Europe,
